Evaluation of blood collection systems

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20486

Enrollment

105

Registered

2018-07-18

Start date

2018-08-01

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In this study the influence of the bloodcollectionsystem on laboratory results is studied on a number of specific laboratory tests.

Interventions

Not applicable.

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers aged over 18 years (40 subjects) Patients using vitamin K antagonists (20 subjects), Patients on heparin therapy (20 subjects) Patients with an decreased Von Willebrandfactor activity (5), protein C deficiency (5), protein S deficiency (5), Factor VIII deficiency (5) or factor IX deficiency (5).

Exclusion criteria

Exclusion criteria: Patients having a decreased hemoglobin (Hb under 7.5 for women and Hb under 8.5 for men)

Design outcomes

Primary

Measure	Time frame
Two collectionsystems (Greiner Bio-One and Becton Dickinson) are studied for specific laboratorytests. Results are evaluated in accordance to the CLSI Evaluation protocol number 9.	—

Secondary

Measure	Time frame
n.a.	—

Contacts

Public ContactAHL Mulder

l.mulder@medlon.nl088-4633326

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)